SE

Shameela Eramangalath Aboobacker

Active Director Director DIN 11823125
DIN 11823125 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Shameela Eramangalath Aboobacker

Shameela Eramangalath Aboobacker is a Director at Acmhans Research Foundation (since 2026).

DIN 11823125
Primary Designation Director
First Appointment 14 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acmhans Research Foundation U85500KL2026NPL104647
Director14 Jul 20262026Active

Directorship timeline

Open interactive timeline →
Acmhans Research Foundation
Premium access

Shareholding and investment profile for Shameela Eramangalath Aboobacker

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shameela Eramangalath Aboobacker

Shameela Eramangalath Aboobacker currently holds 1 directorship: Acmhans Research Foundation (Director, since 14 Jul 2026).

Shameela Eramangalath Aboobacker was first appointed on 14 Jul 2026 as Director at Acmhans Research Foundation.

The current boards of Shameela Eramangalath Aboobacker's companies include Abdul Shukoor N V (Acmhans Research Foundation), Kadambottu Sidheekhassan Sharafudheen (Acmhans Research Foundation), Mundodan Mashood (Acmhans Research Foundation), Najath Vayipokku Parambu (Acmhans Research Foundation), Nirmal Valappil Chettiar (Acmhans Research Foundation), Sadique Kannoth (Acmhans Research Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available